We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

134 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

100% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 29

8% more funds holding

Funds holding: 124 → 134 (+10)

0% more capital invested

Capital invested by funds: $1.01B → $1.01B (+$809K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
134
Holders Change
+10
Holders Change %
+8.06%
% of All Funds
3.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
58
Reduced
29
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.3M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$2.67M
3
NI
Numeric Investors
Massachusetts
+$2.62M
4
Morgan Stanley
Morgan Stanley
New York
+$2.57M
5
Goldman Sachs
Goldman Sachs
New York
+$2.49M

Top Sellers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
-$8.86M
2
BlackRock
BlackRock
New York
-$7.91M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.6M
4
SCA
Secor Capital Advisors
New York
-$1.51M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$4.35M +$2.57M +81,623 +151%
SIM
27
Spark Investment Management
New York
$4.35M -$1.17M -37,100 -21%
MFAM
28
Motley Fool Asset Management
Virginia
$4.23M – – –
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$4.06M +$741K +23,492 +23%
CPA
30
Cowen Prime Advisors
New York
$4.01M +$1.14M +36,229 +41%
AQR Capital Management
31
AQR Capital Management
Connecticut
$3.62M +$1.48M +46,824 +71%
CS
32
Candriam SCA
Luxembourg
$3.18M – – –
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$3.17M -$208K -6,597 -6%
Skandinaviska Enskilda Banken (SEB)
34
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.16M – – –
Citadel Advisors
35
Citadel Advisors
Florida
$3.01M +$2.16M +68,418 +270%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$2.96M -$360K -11,400 -11%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.91M +$27.3K +866 +1%
Ameriprise
38
Ameriprise
Minnesota
$2.78M +$180K +5,721 +7%
UONDDL
39
University of Notre Dame du Lac
Indiana
$2.65M +$74.7K +2,368 +3%
AllianceBernstein
40
AllianceBernstein
Tennessee
$2.41M – – –
SI
41
Scout Investments
Missouri
$2.34M -$788 -25 -0%
OC
42
Oppenheimer & Co
New York
$2.3M -$837K -26,533 -27%
First Manhattan
43
First Manhattan
New York
$2.25M – – –
Wells Fargo
44
Wells Fargo
California
$2.21M +$246K +7,809 +13%
Nordea Investment Management
45
Nordea Investment Management
Sweden
$2.21M +$340K +10,787 +19%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$2.06M +$54.4K +1,726 +3%
GCP
47
GSA Capital Partners
United Kingdom
$2.02M +$606K +19,200 +44%
UBS Group
48
UBS Group
Switzerland
$1.92M +$1.05M +33,391 +127%
EU
49
Emory University
Georgia
$1.72M +$30.9K +980 +2%
TCIM
50
TIAA CREF Investment Management
New York
$1.64M -$51.7K -1,638 -3%
1
2
3 4 5

GHDX Hedge Fund Activity: Q3 2017 in Review

134 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2017, worth a combined $1.01B — up 0.08% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new GHDX positions and 7 closed out — a net gain of 12 holders — while 58 added to existing stakes and 29 trimmed.

The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $8.86M.

  • 134 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2017, up from 124 in Q2 2017.
  • Funds reported $1.01B of Genomic Health, Inc. stock for Q3 2017, up 0.08% quarter-over-quarter.
  • 19 funds opened new Genomic Health, Inc. positions in Q3 2017 and 7 closed out, a net change of +12 holders.
  • The largest Genomic Health, Inc. buyer in Q3 2017 was Millennium Management, an estimated $13.3M added.
  • The largest Genomic Health, Inc. seller in Q3 2017 was Columbia Wanger Asset Management, an estimated $8.86M sold.

Based on aggregated 13F filings for Q3 2017.